Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ronald M Goldenberg

18PUBLICATIONS
48CO-AUTHORS
Social epidemiologyFood properties (incl. characteristics and health benefits)Agricultural biotechnology diagnostics (incl. biosensors)Behavioural epidemiologyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

Sort by Publication Date:
|May 11, 2026
Tirzepatide Versus Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes With Established Cardiovascular Disease: An Indirect Treatment Comparison Meta-Analysis.

|Oct 29, 2025
An indirect treatment comparison of tirzepatide 10 and 15 mg versus high-dose semaglutide 7.2 mg in people with obesity and type 2 diabetes.

Ronald M Goldenberg

|Aug 25, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada.

David A Garcia, Godfrey Mau, Sumeet Singh

|Aug 04, 2025
Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials.

Ronnie Aronson, Alexander Abitbol, Harpreet S Bajaj

|Aug 04, 2025
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta-analysis of observational studies.

Ronald M Goldenberg, Ronnie Aronson, Jill Trinacty

|Mar 18, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5.

Tina Vilsbøll, Ariel Fu, Monika Kellerer

Pageof 3

Frequent Collaborators

3 joint publications

Jill Trinacty

3 joint publications

Jeremy D Gilbert

2 joint publications

Harpreet S Bajaj

2 joint publications

Subodh Verma

2 joint publications

Ronnie Aronson

2 joint publications

Akshay B Jain

2 joint publications

Alice Y Y Cheng

2 joint publications

Vanita R Aroda

1 joint publications

Julio Rosenstock

1 joint publications

Melissa V Hansen

Frequent Collaborators

3 joint publications

Jill Trinacty

3 joint publications

Jeremy D Gilbert

2 joint publications

Harpreet S Bajaj

2 joint publications

Subodh Verma